Early Insights From a Pharmacogenomic-Enriched Comprehensive Medication Management Program Implementation in an Adult Employee Population.
J Occup Environ Med
; 64(12): e818-e822, 2022 12 01.
Article
en En
| MEDLINE
| ID: mdl-36155954
ABSTRACT
OBJECTIVES:
The aims of the study are to assess adoption of a pharmacogenomic-enriched comprehensive medication management program in a self-insured employer setting and to better understand medication risks that affect employees.METHODS:
Employees were identified to be at high risk of medication mismanagement and were subsequently provided with a program and process to improve their health. DNA testing, a clinical decision support system, and pharmacists were used to identify medication safety and effectiveness issues and to recommend appropriate changes.RESULTS:
A total of 10.6% of the invited employees enrolled in the program. Actionable recommendations were suggested by pharmacists for 85.8% of employees who completed the program, averaging 5.2 recommendations per person.CONCLUSIONS:
Implementation of a PGx + CMM program in a self-insured employer setting is feasible, detects risks in prescription regimens, and offers opportunities to improve medication management and reduce the burden of healthcare expenses.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Administración del Tratamiento Farmacológico
Tipo de estudio:
Guideline
/
Prognostic_studies
/
Sysrev_observational_studies
Aspecto:
Implementation_research
Límite:
Adult
/
Humans
Idioma:
En
Revista:
J Occup Environ Med
Asunto de la revista:
MEDICINA OCUPACIONAL
/
SAUDE AMBIENTAL
Año:
2022
Tipo del documento:
Article